EPS (Diluted) for HCA Healthcare (HCA)
According to HCA Healthcare's latest reported financial statements, the company's current diluted EPS (TTM) is $29.08. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$29.08
YoY change
+29.0%
5Y CAGR
+21.0%
Peak year (2025)
$28.38
Latest annual
$28.38
EPS (Diluted) history chart for HCA Healthcare (HCA) from 1990 to 2025
EPS (Diluted) history table for HCA Healthcare (HCA) from 1990 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $28.38 | +29.0% | ||
| 2024 | $22.00 | +16.0% | ||
| 2023 | $18.96 | -1.0% | ||
| 2022 | $19.15 | -9.5% | ||
| 2021 | $21.16 | +93.6% | ||
| 2020 | $10.93 | +8.5% | ||
| 2019 | $10.07 | -5.5% | ||
| 2018 | $10.66 | +79.2% | ||
| 2017 | $5.95 | -18.5% | ||
| 2016 | $7.30 | +46.3% | ||
| 2015 | $4.99 | +20.0% | ||
| 2014 | $4.16 | +23.4% | ||
| 2013 | $3.37 | -3.4% | ||
| 2012 | $3.49 | -29.8% | ||
| 2011 | $4.97 | +80.1% | ||
| 2010 | $2.76 | -8.6% | ||
| 2009 | $3.02 | +56.5% | ||
| 2008 | $1.93 | -23.1% | ||
| 2007 | $2.51 | -0.8% | ||
| 2006 | $2.53 | -20.4% | ||
| 2005 | $3.18 | +23.3% | ||
| 2004 | $2.58 | -1.1% | ||
| 2003 | $2.61 | +64.2% | ||
| 2002 | $1.59 | -3.6% | ||
| 2001 | $1.65 | +312.5% | ||
| 2000 | $0.40 | -64.0% | ||
| 1999 | $1.11 | +52.1% | ||
| 1998 | $0.73 | -258.7% | ||
| 1997 | $-0.46 | -120.7% | ||
| 1996 | $2.22 | +55.2% | ||
| 1995 | $1.43 | -20.6% | ||
| 1994 | $1.80 | +74.8% | ||
| 1993 | $1.03 | +32.1% | ||
| 1992 | $0.78 | +27.9% | ||
| 1991 | $0.61 | +10.9% | ||
| 1990 | $0.55 | — |
EPS (Diluted) values are taken from HCA Healthcare's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of HCA Healthcare (HCA) diluted EPS is $28.38 – grew 29.0% year-over-year.
Through 2020–2025 (5 years), HCA Healthcare diluted EPS delivered a +21.0% annualised rate; sustaining 2 straight years of year-over-year growth.
The dataset's maximum diluted EPS sits at $28.38 (2025); the minimum reading of $-0.46 dates to 1997.
HCA Healthcare (HCA) sits 1st of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
HCA Healthcare EPS (Diluted) by Year
HCA Healthcare EPS (Diluted) 2025: $28.38
HCA Healthcare diluted EPS in 2025 was $28.38, grew 29.0% from 2024. This figure represents the highest annual value in the available history.
HCA Healthcare EPS (Diluted) 2024: $22.00
HCA Healthcare diluted EPS in 2024 was $22.00, grew 16.0% from 2023.
HCA Healthcare EPS (Diluted) 2023: $18.96
HCA Healthcare diluted EPS in 2023 was $18.96, edged down 1.0% below 2022.
HCA Healthcare EPS (Diluted) 2022: $19.15
HCA Healthcare diluted EPS in 2022 was $19.15, declined 9.5% below 2021.
HCA Healthcare EPS (Diluted) 2021: $21.16
HCA Healthcare diluted EPS in 2021 was $21.16.
See more financial history for HCA Healthcare (HCA).
Sector peers — EPS (Diluted)
Companies in the same sector as HCA Healthcare, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is HCA Healthcare's diluted EPS?
- Latest reported diluted EPS for HCA Healthcare (HCA) is $29.08 (period ending March 31, 2026).
How has HCA Healthcare diluted EPS changed year-over-year?
- HCA Healthcare (HCA) diluted EPS changed +29.0% year-over-year on the latest annual filing.
What is the long-term growth rate of HCA Healthcare diluted EPS?
- HCA Healthcare (HCA) diluted EPS compound annual growth rate is +21.0% over the most recent 5 years available.
When did HCA Healthcare diluted EPS hit its highest annual value?
- HCA Healthcare diluted EPS reached its highest annual value of $28.38 in 2025.
What was HCA Healthcare diluted EPS in 2024?
- HCA Healthcare (HCA) diluted EPS in 2024 was $22.00.
What was HCA Healthcare diluted EPS in 2025?
- HCA Healthcare (HCA) diluted EPS in 2025 was $28.38.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
HCA Overview
Company profile, financial tools, and key metrics
HCA Revenue Counter
Earns $2,422 every second. See per minute, hour, and day.
HCA Earnings Counter
Earns $215.44 per second net profit. See per minute, hour, and day.
HCA Economic Scale
Exceeds Belarus's GDP. Compare with world economies.
HCA What If Invested
What if you had invested $1,000? See historical returns from any date.
HCA How It Makes Money
Discover visual breakdown of $76.39B in revenue — where it comes from and where it goes.
HCA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HCA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HCA Daily Price Character
Balanced · 52.3% historical win rate (green days). Streaks & record days.
HCA Buybacks
8.51% TTM buyback yield. Shareholder yield & SBC comparison.
HCA Dividend Profile
Yield: 0.68%. Safety: 5/7. See full history.
HCA Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
HCA Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.